February 16, 2021
Monteverde & Associates attorneys won a $5.8 million fee award Tuesday for representation of stockholders in a $17.4 million settlement resolving claims that Envision Healthcare Corp. executives undervalued the company ahead of its $9.9 billion sale to private equity firm KKR & Co. LP.
April 13, 2020
A stockholder sought class certification Monday in Delaware federal court for his securities claims that Envision Healthcare Corp. tamped down company value estimates ahead of an allegedly unfair $9.9 billion cash and debt sale to private equity firm KKR & Co. LP in 2018.
November 05, 2018
Monteverde & Associates won a lead counsel appointment in the consolidation of two class actions in a Delaware federal court Monday over the $9.9 billion sale of Envision Healthcare Corp. to private equity firm KKR & Co. LP, in which shareholders claim executives took part in a flawed sales process that undervalued the company.